In the interaction with NK cells, melanoma cells express increased prostaglandin E2 (PGE2) and IDO, leading to the shrinkage of activating receptors on NK cells and thus attenuating NKs’ capability of binding to and killing melanoma cells (25). The gene discussed is IDO1; the disease is melanoma.